NASDAQ · Biotechnology

INCY (INCY) Stock

$128.83 +3.06% NASDAQ: INCY Healthcare

Valuation

MetricValue
Price$128.83
Market Cap$26.11B
P/E Ratio15.30
P/B Ratio3.93
P/S Ratio4.33
EPS (TTM)$7.08
52-Week High$132.60
52-Week Low$81.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE29.70%
ROA20.48%
ROCE28.01%
Gross Margin52.77%
Operating Margin25.55%
Net Margin27.71%
Debt/Equity0.01
Current Ratio3.68

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.0B$3.4B$3.7B$4.2B$5.1B
Operating Profit$586.0M$592.0M$655.0M$101.0M$1.3B
Net Profit$949.0M$341.0M$598.0M$33.0M$1.3B
EPS$4.27$1.52$2.65$0.15$6.41
Op Margin19.6%17.4%17.7%2.4%26.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$4.9B$5.8B$6.8B$5.4B$7.0B
Total Liabilities$1.2B$1.5B$1.6B$2.0B$1.8B
Cash$2.1B$3.0B$3.2B$1.7B$3.1B
Borrowings$45.0M$41.0M$38.0M$44.0M$69.0M

Latest News

2 Fast-Growing Pharmaceutical Stocks to Buy Now Motley Fool · Jul 9, 2026 Collect 9.0% On VRTX Stock Now, And Still Keep 15% Of Upside Trefis · Jul 8, 2026 Incyte to Report Second Quarter Financial Results Business Wire · Jul 8, 2026 RBC Capital Adjusts Incyte Price Target to $99 From $95, Maintains Sector Perform Rating MT Newswires · Jul 7, 2026 Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio Business Wire · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$749.0M$970.0M$496.0M$335.0M$1.4B
Investing Cash Flow$-389.0M$-156.0M$-255.0M$71.0M$-161.0M
Financing Cash Flow$-50.0M$-59.0M$-53.0M$-2.1B$-116.0M
Net Cash Flow$544.0M$894.0M$262.0M$-1.5B$1.4B
Free Cash Flow$568.0M$892.0M$449.0M$249.0M$1.4B

Valuation & Return Ratios

MetricValue
PEG Ratio0.19
EV / EBITDA10.42
FCF Yield7.62%
Quick Ratio4.58
Interest Coverage790.59
Return 1Y48.59%
Return 3Y92.55%
Return 5Y69.29%

Ownership

Insiders Held1.89%
Institutions Held106.59%
Institutions Float Held108.64%
Institutional HolderSharesReport Date
Baker Bros. Advisors, LP30,744,4122026-03-31
Blackrock Inc.18,978,1982026-03-31
Dodge & Cox Inc.12,252,3562026-03-31
Vanguard Capital Management LLC10,930,0662026-03-31
State Street Corporation9,641,3842026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIIB $222.67 +3.07% 38.92 $32.90B 0.00%
DGX $240.80 +1.94% 21.70 $26.58B 1.68%
GMABGenmab A/S $29.00 -2.62% 21.45 $17.80B 0.00%
ILMN $213.25 +2.95% 41.56 $32.26B 0.00%
RPRX $63.11 +1.27% 25.25 $27.98B 1.54%

About INCY

INCY is led by CEO William J. Meury, employs 2,844 people, headquartered in Wilmington, US, publicly traded since 1993.

INCY stock trades at $128.83 with a market capitalization of $26.11B. The stock is valued at a price-to-earnings (P/E) ratio of 15.30, price-to-book of 3.93, price-to-sales of 4.33. Over the past 52 weeks the stock has ranged between $81.09 and $132.60, and currently trades 2.8% below its 52-week high.

On profitability, INCY generates a return on equity (ROE) of 29.70% — well above the market average, a sign of a high-quality business, return on capital employed of 28.01%, an operating margin of 25.55%, a net profit margin of 27.71%.

In its most recent fiscal year, INCY reported annual revenue of $5.1B, net profit of $1.3B, revenue has compounded at 14.0% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of 0.01 — a conservative balance sheet with little leverage risk, a current ratio of 3.68, total assets of $7.0B, $3.1B in cash and equivalents.

INCY has a beta of 0.77 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides